Patent details

EP3512870 Title: SCN9A ANTISENSE OLIGONUCLEOTIDES

Basic Information

Publication number:
EP3512870
PCT Application Number:
IB2017000751
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP178503546
PCT Publication Number:
WO2018051175
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SCN9A ANTISENSE OLIGONUCLEOTIDES
French Title of Invention:
OLIGONUCLÉOTIDES ANTISENS SCN9A
German Title of Invention:
SCN9A-ANTISENSE-OLIGONUKLEOTIDE
SPC Number:

Dates

Filing date:
24/05/2017
Grant date:
03/08/2022
EP Publication Date:
24/07/2019
PCT Publication Date:
22/03/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
03/08/2022
EP B1 Publication Date:
03/08/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
24/05/2023
Expiration date:
24/05/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
27/07/2022
 
 

Name:
Olipass Corporation
Address:
20th Floor Ace Dongbaek Tower 16 Beon-gil 16-7 Dongbaek Jungang-ro Giheung-gu, Yongin-si, Gyeonggi-do 17015, Korea (Republic) (KR)

Inventor

1

Name:
CHO, Bongjun
Address:
Korea (Republic) (KR)

2

Name:
JANG, Kangwon
Address:
Korea (Republic) (KR)

3

Name:
CHUNG, Shin
Address:
Korea (Republic) (KR)

4

Name:
JUNG, Daram
Address:
Korea (Republic) (KR)

5

Name:
YOON, Heungsik
Address:
Korea (Republic) (KR)

Priority

Priority Number:
201662395814 P
Priority Date:
16/09/2016
Priority Country:
United States (US)

Classification

IPC classification:
C12N 15/113; A61K 31/7088; A61P 25/02;

Publication

European Patent Bulletin

Issue number:
202231
Publication date:
03/08/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages